Replies to post #370531 on Innovation Pharmaceuticals Inc (IPIX)

[olden_grumpini]

Yeah, seeking EUA on 12 subjects treated in their P2. Got go-ahead for P3 on Aug 5th.

In P2, age group >85 years, 91% of those treated survived. Still, they had just 12 subjects in the treatment arm. Will be interesting to see how this goes.

Here's the paper with P2 results, including AEs, etc.: Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial

BTW: The company was formed in 2007, has 4 employees, a market cap of $140m, and trades on the OTC. They're up >500% in 1 year.